Anatolia Tanı ve Biyoteknoloji A.Ş. logo

Anatolia Tanı ve Biyoteknoloji A.Ş. (ANGEN)

Market Closed
12 Dec, 15:00
XIST XIST
11. 76
+0.12
+1.03%
2.96B Market Cap
- P/E Ratio
2.38% Div Yield
2,090,266 Volume
- Eps
11.64
Previous Close
Day Range
11.66 12.07
Year Range
9.6 16.45
Want to track ANGEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ANGEN closed Friday higher at ₺11.76, an increase of 1.03% from Thursday's close, completing a monthly increase of 3.34% or ₺0.38. Over the past 12 months, ANGEN stock lost -5.16%.
ANGEN is not paying dividends to its shareholders.
Anatolia Tanı ve Biyoteknoloji A.Ş. has completed 1 stock splits, with the recent split occurring on May 18, 2023.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XIST (TRY).

ANGEN Chart

Similar

Adel Kalemcilik Ticaret Ve Sanayi A.S.
31.32
-1.01%
Tapdi Oksijen Özel Sağlik Hizmetleri A.Ş.
21.74
-0.28%
Oncosem Onkolojik Sistemler A.Ş.
275.25
-0.36%
Meditera Tibbi Malzeme Sanayi A.Ş.
28.4
+0.5%
Lokman Hekim Engurusag Saglik Hizmetleri A.S.
16.75
+3.78%

Anatolia Tanı ve Biyoteknoloji A.Ş. (ANGEN) FAQ

What is the stock price today?

The current price is ₺11.76.

On which exchange is it traded?

Anatolia Tanı ve Biyoteknoloji A.Ş. is listed on XIST.

What is its stock symbol?

The ticker symbol is ANGEN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.38%.

What is its market cap?

As of today, the market cap is 2.96B.

Has Anatolia Tanı ve Biyoteknoloji A.Ş. ever had a stock split?

Anatolia Tanı ve Biyoteknoloji A.Ş. had 1 splits and the recent split was on May 18, 2023.

Anatolia Tanı ve Biyoteknoloji A.Ş. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
XIST Exchange
TREANGN00028 ISIN
Turkey Country
257 Employees
- Last Dividend
18 May 2023 Last Split
- IPO Date

Overview

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is a prominent biotechnology enterprise based in Istanbul, Turkey, focusing on the innovation, development, and production of various biotechnology products. The company specializes in real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It positions itself as a key player in the biotech industry by catering to a wide array of needs within the field, from disease detection to genetic research, showcasing a strong commitment to advancing healthcare and research technologies.

Products and Services

Anatolia Tani ve Biyoteknoloji offers an extensive range of products and services designed for diagnostics, research, and healthcare applications, including:

  • Microbiology Kits: For the detection and analysis of microbial pathogens. These kits are vital tools in diagnosing various bacterial and viral infections, ensuring timely and effective treatment.
  • Genetic Disorder Kits: Designed for the identification of genetic disorders. These kits play a crucial role in early detection of hereditary and genetic conditions, enabling proactive healthcare measures.
  • Panel Kits: Comprehensive test panels for multiple pathogens or genetic markers. These kits offer a broad spectrum analysis, providing significant advantages in diagnostics and patient care.
  • Sequencing Kits: Facilitating advanced research in genomics. These kits support the detailed analysis of genetic sequences, contributing to scientific advancements and personalised medicine.
  • Food Testing Kits: Essential for ensuring food safety and quality. These kits detect contaminants and pathogens in food products, thereby safeguarding public health.
  • Manual Spin Column and Magnetic Bead Nucleic Acid Extraction Kits: Crucial for the purification of DNA and RNA, these kits are essential in preparing samples for further analysis and research.
  • Automated NA Extraction Instrument Kits: Streamlining the process of nucleic acid extraction. These kits, designed for use with specific automated instruments, enhance efficiency and consistency in the extraction process.

The company's offerings are instrumental in diagnosing and researching diseases such as brucellosis, chlamydia, hepatitis, HIV, and novel coronavirus (SARS-CoV-2), among others. Furthermore, they provide crucial tools in the study of genetic diseases and conditions, marking Anatolia Tani ve Biyoteknoloji as a key contributor to the fields of diagnostics, public health, and biomedical research.

Contact Information

Address: Hasanpasa Mah.
Phone: 90 216 330 04 55